Tags: nanomedicine

Description

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials. More information on Nanomedicine can be found here.

Resources (1-20 of 157)

  1. 2005 Oncological Sciences Center Symposium

    16 Aug 2005 |

    Progress and Problems inCancer Treatment and Prevention

  2. 2005 Oncological Sciences Center Symposium Agenda

    07 Dec 2006 |

  3. 2008 BioNano Technology and Pharmaceuticals

    06 Aug 2008 | | Contributor(s):: Pankaj Sharma, Nalam Madhusudhana Rao

    The purpose of this symposium is to bring together top scientists from India and the United States to present their latest work and to discuss future international scientific collaborative partnerships. This one and a half day symposium will also feature a special second half day mini-symposium...

  4. <i>In Vivo</i> Nuclear Magnetic Resonance Imaging and Spectroscopic Investigations of Structure and Function of Rodent Brain

    30 Jul 2008 | | Contributor(s):: Anant B. Patel

    Nuclear Magnetic Resonance Imaging (MRI) is a powerful and a versatile imaging modality for non-invasive characterization of host structure and function. MRI has grown in many directions such as functional MRI, diffusion tensor imaging, chemical shift imaging, which is used to detect single...

  5. An Introduction to BioMEMS and Bionanotechnology

    07 Feb 2005 | | Contributor(s):: Rashid Bashir

    This lecture series introduces the basic concepts and key topics underlying the interdisciplinary areas of BioMEMS and Bionanotechnology. Advances in this field require the knowledge of polymer processing and soft lithography in addition to knowledge of silicon-inspired fabrication. Since the...

  6. Antiestrogenic Conjugates as New Breast Cancer Chemoprevention Agents

    08 Mar 2007 | | Contributor(s):: Ross Weatherman

    Tamoxifen is the first drug specifically approved for the prevention of cancer and arguably the most successful anticancer drug of all time. Although millions of breast cancer patients have benefited from tamoxifen therapy, there are side effects that hinder the broad use of tamoxifen as a...

  7. Application of Dynamic Light Scattering in the Physicochemical Characterization of Natural and Engineered Nanoparticles

    20 Apr 2012 | | Contributor(s):: Trisha Eustaquio

    This presentation will highlight the use of dynamic light scattering (DLS), which measures the hydrodynamic size of nanoparticles in suspension, in characterizing specific examples of engineered and natural nanoparticles. In terms of engineered nanoparticles, the role of nanoparticle size in...

  8. BioMEMS and Bionano Devices for Bio/Medicine

    26 Jul 2004 | | Contributor(s):: Rashid Bashir

    BioMEMS and Bionano Devices for Bio/Medicine

  9. biomoca

    30 May 2006 | | Contributor(s):: Reza Toghraee, Umberto Ravaioli

    Ion channel simulator

  10. BioNanotechnology and Nanomedicine Lecture 25: Force Traction Microscopy

    16 Nov 2011 | | Contributor(s):: Javid Mohammed Ali

    BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology provides an introduction to basic concepts of nanotechnology in mechanobiology and in cancer. This is a highly interdisciplinary field of research where knowledge from various disciplines is presented and integrated....

  11. Biosensing applications of Plasmon Resonance in gold nanoparticles

    02 Aug 2007 | | Contributor(s):: Karina Moore

    Light can be used to excite plasmon resonance in gold nanoparticles. Plasmon resonance occurs on the nanoscale as the particles become excited and plasmon oscillations arise in each particle of a pair of metal nanoparticles. There is plasmon coupling between the neighboring particles as the...

  12. BME 695L Lecture 10: Nanodelivery of Therapeutic Genes and Molecular Biosensor Feedback Control Systems

    10 Oct 2011 | | Contributor(s):: James Leary

    See references below for related reading.10.1      Introduction and overview10.1.1    Some of the advantages of therapeutic genes10.1.2    Some of the advantages of molecular biosensor feedback control...

  13. BME 695L Lecture 11: Assessing Nanotoxicity at the Single Cell Level

    10 Oct 2011 | | Contributor(s):: James Leary

    See references below for related reading.11.1      Need for single cell measures of nanotoxicity11.1.1    There is more than one way for a cell to die...11.1.2    "Necrosis" vs. "Apoptosis"11.1.3    There...

  14. BME 695L Lecture 12: Assessing Drug Efficacy and Nanotoxicity at the Single Cell Level

    01 Nov 2011 | | Contributor(s):: James Leary

    See references below for related reading.12.1      Introduction to measures of efficacy for nanomedicine12.1.1    for evaluation purposes, does structure/size reveal function?12.1.2    nanomedical treatment at the single cell...

  15. BME 695L Lecture 13: Designing Nanomedical Systems (NMS) for In-vivo Use

    10 Nov 2011 | | Contributor(s):: James Leary

    See references below for related reading.13.1      Bringing in-vivo considerations into NMS design13.1.1    the in-vitro to ex-vivo to in-vivo paradigm         13.1.1.1 In-vitro - importance of...

  16. BME 695L Lecture 14: Designing and Testing Integrated Nanomedical Systems

    10 Nov 2011 | | Contributor(s):: James Leary

    See references below for related reading.14.1      Introduction to integrated designs14.1.1    “Total design” but there is some order in the design process14.1.2    A brief outline of the total design...

  17. BME 695L Lecture 15: GMP and Issues of Quality Control Manufacture of Nanodelivery Systems

    10 Nov 2011 | | Contributor(s):: James Leary

    See references below for related reading.15.1      Overview15.1.1    What does cGMP mean?15.1.2    Why GMP? Controlling processes means more predictable...

  18. BME 695L Lecture 16: FDA and EPA Regulatory Issues

    10 Nov 2011 | | Contributor(s):: James Leary

    See references below for related reading.16.1      Introduction and overview16.1.1    How does the FDA think about nanomedical systems?16.1.2    The 2006 Nanotechnology Task Force16.2      Some...

  19. BME 695L Lecture 1: Need for New Perspectives on Medicine

    31 Aug 2011 | | Contributor(s):: James Leary

    See references below for related reading.1.1      Nanotechnology – Why is something so small so big?1.1.1    Definitions of nanotechnology based on size1.1.2    A “bottoms up” rather than “tops down”...

  20. BME 695L Lecture 2: Designing Nanomedical Systems

    31 Aug 2011 | | Contributor(s):: James Leary

    See references below for related reading.2.1       Elements of good engineering design2.1.1    Whenever possible, use a general design that has already been tested2.1.2    Whenever possible, take advantage of “biomimicry” –...